Recent news on Paraplatin

GPC Biotech Announces Election of Donald Soltysiak to Supervisory ...  -  25 May 2007
PR Newswire (press release),He was responsible for several successful product launches of key oncology drugs, including Paraplatin(R) (carboplatin) and Taxol(R) (paclitaxel).

Lung Cancer is the Third Most Common Malignant Disease and the ...  -  May 13, 2007
Fuerteventura Digital,...drugs go off patent before 2012; Aventis’ Taxotere (docetaxel), Bristol-Myers Squibb’s Paraplatin (carboplatin) and Eli Lilly’s Gemzar (gemcitabine).

FDA Warns of Possible Bevacizumab Fistula Complication  -  Apr 23, 2007
MedPage Today,...which was closed to new accruals on March 12, combined four cycles of concurrent irinotecan (Campto), carboplatin (Paraplatin), radiation therapy,

Study Reviews Chemotherapy for Advanced Biliary Tract Cancer  -  Apr 4, 2007
Cancer Consultants (press release),Platinum chemotherapy drugs include Platinol® (cisplatin), Eloxatin® (oxaliplatin), and Paraplatin® (carboplatin). Because many of the reviewed studies had

Surgery to Remove Recurrent Ovarian Cancer Provides Favorable Survival  -  Mar 30, 2007
Cancer Consultants (press release),Participants had received prior surgery followed by chemotherapy with a platinum agent (Platinol® [cisplatin] or Paraplatin® [carboplatin]).

Novartis licences lead cancer candidate from Antisoma  -  Apr 23, 2007
In-PharmaTechnologist.com,...treatment of paclitaxel and carboplatin (Bristol-Myers Squibb as Taxol and Paraplatin) originally marketed by than with the chemotherapy alone.

Windfall for cos eyeing US oncology market  -  Apr 10, 2007
Economic Times,...anti-cancer drug in the US market —a generic version of Bristol Myers Squibb’s Paraplatin (generic name Carboplatin), which got off patent in October 2004.

Study Evaluates Chemotherapy with Gemzar® and Paraplatin® in Lung ...  -  Mar 7, 2007
Cancer Consultants (press release),Median survival was 4.8 months among patients treated with Gemzar alone compared with 6.7 months among patients treated with Gemzar plus Paraplatin.

Doxil®/Paraplatin® Effective in Recurrent Ovarian Cancer  -  Feb 21, 2007
Cancer Consultants (press release),According to an article recently published in the Annals of Oncology, treatment consisting of Doxil® (pegylated liposomal doxorubicin) and Paraplatin®

Paraplatin®/Cytoxan® a Possible Alternative for Ovarian Cancer  -  Feb 20, 2007
Cancer Consultants (press release),According to an article recently published in the Annals of Oncology, the chemotherapy combination consisting of Paraplatin® (carboplatin) plus Cytoxan®

Camptosar® Evaluated in Children with Relapsed or Refractory ...  -  Feb 14, 2007
Cancer Consultants (press release),Adriamycin® (doxorubicin), Actinomycin D® (dactinomycin), Vepesid® (etoposide), Platinol® (cisplatin), and Paraplatin® (carboplatin).

Intraperitoneal Chemotherapy in First Line Therapy Improves ...  -  Feb 8, 2007
Cancer Consultants (press release),A recent phase II trial showed promising results with the administration of intraperitoneal Hycamtin® following Taxol® and Paraplatin® therapy.

Avastin® Improves Survival in Advanced Non-Small Cell Lung Cancer  -  Jan 12, 2007
Cancer Consultants (press release),The trial included 878 patients with advanced or recurrent NSCLC who were randomly assigned to receive Avastin/Taxol/Paraplatin or Taxol/Paraplatin only.

Cetuximab (Erbitux®) Combinations Evaluated in Rectal and ...  -  Jan 2, 2007
Cancer Consultants (press release),...study of cetuximab, Taxol® (paclitaxel), Paraplatin® (carboplatin) and radiotherapy for the treatment of patients with non-metastatic esophageal cancer.

Erbitux® Combinations Evaluated in Rectal and Esophageal Cancer  -  Jan 2, 2007
Cancer Consultants (press release),Taxol® (paclitaxel), Paraplatin® (carboplatin), and radiation therapy for the treatment of patients with non-metastatic esophageal cancer.[2]

Fractionated Camptosar® Plus Paraplatin® Well Tolerated in ...  -  Dec 1, 2006
Cancer Consultants (press release),Researchers from Korea have reported that a regimen of fractionated Camptosar (irinotecan) plus Paraplatin (carboplatin) is a well tolerated regimen for

Doxil® and Paraplatin® Effective for Recurrent Ovarian Cancer  -  Nov 30, 2006
Cancer Consultants (press release),The current study evaluated the combination of Doxil and Paraplatin in 104 women with advanced ovarian cancer who had relapsed more than 6 months after

Avastin Adds Two Months to Lung Cancer Survival, at a Price  -  Dec 13, 2006
MedPage Today,But, Dr. Sandler and colleagues pointed out, there were 15 treatment related deaths in the Avastin arm versus two in the Taxol/Paraplatin arm.

Role of Nexavar® in NSCLC Reviewed  -  Nov 30, 2006
Cancer Consultants (press release),In another phase I/II clinical trial, Nexavar was combined with Taxol® (paclitaxel) and Paraplatin® (carboplatin) for treatment of 15 patients with advanced

No Added Benefit of Taxol® Following Chemotherapy/Radiation in ...  -  Nov 29, 2006
Cancer Consultants (press release),Patients without cancer progression following Paraplatin/VePesid/radiation therapy went on to receive consolidation Taxol. Results from this trial were

Herceptin: Safe Breast Cancer Stopper  -  Dec 15, 2006
WebMDAn experimental regimen of Taxotere and Paraplatin with one year of Herceptin. The results showed that after three years, women who took either of the

Low Hematologic Toxicity Rate for Gemzar® and Ellence® in Advanced ...  -  Nov 28, 2006
Cancer Consultants (press release),These authors concluded that the GEMOX regimen should be tested in a phase III study versus Paraplatin and Gemzar in patients not suitable for Platinol

Split Doses of Paraplatin® Decrease Severe Thrombocytopenia in ...  Oct 30, 2006
According to an article recently published in Clinical Lung Cancer, two administrations of lower-dose Paraplatin® (carboplatin) maintains long-term outcomes ... -Cancer Consultants (press release), Split Dose Paraplatin® Decreases Severe Thrombocytopenia in ...  Nov 1, 2006
German researchers have reported that split-dose Paraplatin (carboplatin) decreases the incidence of severe thrombocytopenia from 51% to 35% compared to a ... -Cancer Consultants (press release), Alimta® Safe and Active in Small Cell Lung Cancer  Oct 27, 2006
...of Clinical Oncology, the addition of the chemotherapy agent Alimta® (pemetrexed) to either Platinol® (cisplatin) or Paraplatin® (carboplatin) provides a ... -Cancer Consultants (press release), Alimta® Safe and Active in Small Cell Lung Cancer  Oct 24, 2006
...in a multicenter randomized phase II trial have reported that Alimta® (pemetrexed) and either Platinol® (cisplatin) or Paraplatin® (carboplatin) provides a ... -Cancer Consultants (press release), Avastin® Approved for Initial Therapy of NSCLC  Oct 18, 2006
...the United States Food and Drug Administration (FDA) to market Avastin (bevacizumab), in combination with Taxol(paclitaxel) and Paraplatin (carboplatin), as ... -Cancer Consultants (press release), Avastin® Approved for Initial Treatment of Non–Small Cell Lung ...  Oct 12, 2006
The United States Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) for use in combination with Paraplatin® (carboplatin) and Taxol ... -Cancer Consultants (press release), IASLC: When Cox-2 Is Over-Expressed in NSCLC, Celebrex May Give ...  Nov 2, 2006
...tumor over-expression of Cox-2 was a marker of poor outcome for patients undergoing first line therapy with the combination of Paraplatin (carboplatin) and ... -MedPage Today, Average Increase in Price of Cancer Drugs Below CPI Trend  Oct 9, 2006
...cancer, increased 10% in 2006 while the cost of carboplatin therapy was reduced by approximately 20% due to generic availability of Paraplatin, the branded drug ... -Genetic Engineering News (press release), FDA Gives Avastin First-Line NSCLC Indication  Oct 12, 2006
12 -- The FDA has approved Avastin (bevacizumab), in combination with Taxol (paclitaxel) and Paraplatin (carboplatin), as first-line therapy for non-small-cell ... -MedPage Today, Addition of Gemzar® to Paraplatin® Improves Progression-free ...  Sep 18, 2006
According to an article recently published in the Journal of Clinical Oncology, the addition of Gemzar® (gemcitabine) to Paraplatin® (carboplatin) improves ... -Cancer Consultants

Addition of Gemzar® to Paraplatin® Improves Progression-Free ...  Sep 20, 2006
An international trial has determined that the combination of Gemzar (gemcitabine) and Paraplatin (carboplatin) is superior to Paraplatin alone for the ... -Cancer Consultants

Induction Chemotherapy and Preoperative Chemoradiotherapy Improve ...  Aug 29, 2006
Patients in the concurrent chemoradiotherapy group received radiotherapy up to 50.4 Gy, and concurrent chemotherapy with Paraplatin and 5-FU or Taxol and ... -Cancer Consultants

Chemotherapy plus Radiation Superior to Radiation Alone Following ...  Sep 20, 2006
214 patients with Stages IIIA or IIIB who were initially treated with the chemotherapy agents Taxol® (paclitaxel) and Paraplatin® (carboplatin), followed by ... -Cancer Consultants

Bristol-Myers outlook still rocky  Sep 12, 2006
...enough new drugs to offset sales declines for older products facing generic competition, including cholesterol fighter Pravachol and cancer drug Paraplatin. ... -Washington Post

Doxil®/Gemzar® Effective for Recurrent Ovarian Cancer  Aug 31, 2006
...plus Doxil in patients with ovarian cancer that has stopped responding to prior therapy with a standard platinum chemotherapy agent (Platinol or Paraplatin). ... -Cancer Consultants

Fractionated Camptosar® Plus Paraplatin® Well Tolerated in ...  -  Dec 1, 2006
Cancer Consultants (press release),Researchers from Korea have reported that a regimen of fractionated Camptosar (irinotecan) plus Paraplatin (carboplatin) is a well tolerated regimen for

Doxil® and Paraplatin® Effective for Recurrent Ovarian Cancer  -  Nov 30, 2006
Cancer Consultants (press release),The current study evaluated the combination of Doxil and Paraplatin in 104 women with advanced ovarian cancer who had relapsed more than 6 months after

Role of Nexavar® in NSCLC Reviewed  -  Nov 30, 2006
Cancer Consultants (press release),In another phase I/II clinical trial, Nexavar was combined with Taxol® (paclitaxel) and Paraplatin® (carboplatin) for treatment of 15 patients with advanced

No Added Benefit of Taxol® Following Chemotherapy/Radiation in ...  -  Nov 29, 2006
Cancer Consultants (press release),Patients without cancer progression following Paraplatin/VePesid/radiation therapy went on to receive consolidation Taxol. Results from this trial were

Low Hematologic Toxicity Rate for Gemzar® and Ellence® in Advanced ...  -  Nov 28, 2006
Cancer Consultants (press release),These authors concluded that the GEMOX regimen should be tested in a phase III study versus Paraplatin and Gemzar in patients not suitable for Platinol

Induction Chemotherapy and Preoperative Chemoradiotherapy Improve ...  29 Aug 2006
Patients in the concurrent chemoradiotherapy group received radiotherapy up to 50.4 Gy, and concurrent chemotherapy with Paraplatin and 5-FU or Taxol and ... -Cancer Consultants

Paraplatin®, Camptosar® Supported by Neupogen® Well Tolerated ...  Aug 4, 2006
Researchers from Japan have reported that a regimen of Paraplatin (carboplatin) and Camptosar (irinotecan) supported by Neupogen was effective and well ... -Cancer Consultants

Eloxatin® and Taxotere® Safe and Effective Palliation for ...  Aug 22, 2006
The combination of Taxotere and Platinol® (cisplatin) or Taxotere and Paraplatin® are among the most favored first line therapies for palliation of advanced ... -Cancer Consultants

Triple-Chemo Regimen No Improvement in Ovarian Cancer  Aug 1, 2006
Rather than improving outcome, the addition of Hycamtin to the Paraplatin(carboplatin) and Taxol (paclitaxel) regimen was associated with a non-significant ... -MedPage Today

Platinum combined with radiotherapy for cancer treatment - 15th ...  Aug 15, 2006
...research team treated 31 patients with locally advanced head and neck cancer with a number of different induction regimens including Platinol and Paraplatin. ... -Platinum today

Eloxatin® and Gemzar® a Tolerable Regimen for Advanced or ...  Aug 16, 2006
Other regimens with high activity in patients with advanced bladder cancer include Taxotere/Gemzar and Gemzar/Paraplatin® (carboplatin). ... -Cancer Consultants

Taxotere® (Docetaxel)-Platinum Combinations Improve Quality of ...  Aug 4, 2006
Researchers have reported that the chemotherapy combinations of Taxotere and Platinol® (cisplatin) or Taxotere and Paraplatin® (carboplatin) results in ... -Cancer Consultants

Head and neck cancer: Docetaxel combined with standard ...  Aug 21, 2006
...with a combination of drugs followed by simultaneous fractionated radiation therapy and weekly treatment with Carboplatin ( Paraplatin ) chemotherapy. ... -Xagena.it

Chemotherapy Followed by Taxotere® plus Radiation Provides ...  Aug 15, 2006
...a clinical trial to evaluate a treatment regimen consisting of initial chemotherapy with Platinol® (cisplatin) and 5-fluorouracil, Paraplatin® (carboplatin)/5 ... -Cancer Consultants

Tandem Autologous Transplants Effective for High-Risk ...  Aug 21, 2006
The myeloablative regimen consisted of Alkeran, Vepesid® (etoposide) and Paraplatin® (carboplatin).The 3-year EFS was 53% for the high-dose group and 30% for ... -Cancer Consultants

Induction Chemotherapy and Concomitant Taxotere® and Radiation ...  Aug 14, 2006
The induction regimens in this trial were Platinol® (cisplatin) and 5-fluorouracil (5-FU), Paraplatin® (carboplatin) and 5-FU or Taxotere, Platinol and 5-FU. ... -Cancer Consultants

Taxotere® plus Platinum Compounds Improves Quality of Life over ...  Aug 7, 2006
The TAX 326 trial included over 900 patients with advanced NSCLC who were treated with either Taxotere plus carboplatin (Paraplatin®), Navelbine plus ... -Cancer Consultants

Ovarian Cancer Drug Combination Identified at Rational ...  Jul 28, 2006
The activity for Cisplatin and its derivative Carboplatin (Paraplatin, Bristol Meyers Squibb) plus the pancreatic cancer drug Gemcitabine (Gemzar, Eli Lilly ... -Business Wire

Addition of Hycamtin® to Standard Therapy Does Not Improve ...  Aug 3, 2006
...of the National Cancer Institute, the addition of Hycamtin® (topotecan) to the standard chemotherapy combination including carboplatin (Paraplatin®) and Taxol ... -Cancer Consultants

FDA Okays Gemzar-Paraplatin Duo for Recurrent Ovarian Cancer  Jul 17, 2006
INDIANAPOLIS, July 17 -- The FDA has approved Gemzar (gemcitabine) in combination with Paraplatin (carboplatin) for treatment of recurrent ovarian cancer, Eli ... -MedPage Today

Velcade® Plus Gemzar®/Paraplatin® Highly Active in Advanced ...  Jul 10, 2006
...of Clinical Oncology (ASCO), the treatment combination consisting of Velcade (bortezomib) plus Gemzar (gemcitabine) plus Paraplatin (carboplatin) provides ... -Cancer Consultants

Gemzar® Approved for Recurrent Ovarian Cancer  Jul 19, 2006
The approved indication includes the use of Gemzar in combination with Paraplatin® (carboplatin) in patients whose cancer has returned or progressed at least ... -Cancer Consultants

Gemzar® Combined with Eloxatin® or Platinol® Improves Survival ...  Jul 17, 2006
Eloxatin is being increasingly evaluated in platinum-sensitive cancers as it is possible less toxic than Platinol or Paraplatin® (carboplatin). ... -Cancer Consultants

Addition of Carboplatin to Taxol®/Herceptin® Improves ...  Jun 27, 2006
According to an article recently published in the Journal of Clinical Oncology, the addition of carboplatin (Paraplatin®) to Taxol® (paclitaxel) and Herceptin ... -Cancer Consultants



Herceptin® May Change the Natural History of Patients with HER2 ...  May 1, 2006
...been combined with non-cardiotoxic agents such as Navelbine, Taxotere® (docetaxel), Taxol® (paclitaxel), cisplatin (Platinol®), and Paraplatin® (carboplatin ... - Cancer Consultants

Camptosar®/Carboplatin Improves Progression-Free Survival over ...  Apr 21, 2006
...to an article published in the Annals of Oncology, the chemotherapy combination consisting of Camptosar® (irinotecan) plus Paraplatin® (carboplatin) appears ... - Cancer Consultants





Gemzar®/Paraplatin® Followed by Taxol®/Paraplatin® as Initial ...  Mar 28, 2006
...recently published in the journal Gynecologic Oncology, the chemotherapy regimen consisting of Gemzar® (gemcitabine) plus Paraplatin® (carboplatin) followed ... - Cancer Consultants

Taxol® and Paraplatin® Superior to Novantrone® for Hormone ...  Mar 10, 2006
According to an article recently published in the journal Urology, treatment consisting of Taxol® (paclitaxel) and Paraplatin® (carboplatin) provides ... - Cancer Consultants

Taxol® and Paraplatin® Superior to Novantrone® for Hormone ...  Mar 10, 2006
Researchers from France have reported that the combination of Taxol (paclitaxel) and Paraplatin (carboplatin) is superior to Novantrone (mitoxantrone) for the ... - Cancer Consultants

Alimta® and Paraplatin® Effective and Well-Tolerated in ...  Mar 22, 2006
...article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Alimta® (pemetrexed) and Paraplatin® (carboplatin) is ... - Cancer Consultants

Updated Guidelines for Treatment of Ovarian Cancer  Mar 27, 2006
...months after stopping chemotherapy, the following chemotherapy regimens were added as treatment options: Gemzar® (gemcitabine)/Paraplatin® (carboplatin) and ... - Cancer Consultants

Taxotere® plus Gemzar® is an Effective Regimen for Advanced Soft ...  Apr 4, 2006
...and alkylating agents such as Ifex® (ifosfamide) and dacarbazine, (DTIC®) platinum compounds such as Platinol® (cisplatin) and Paraplatin® (carboplatin) or ... - Cancer Consultants

Concurrent Radiation Therapy and Chemotherapy for Small Cell Lung ...  Mar 16, 2006
5-year survival of patients with limited small cell lung cancer (SCLC) following concurrent radiotherapy and chemotherapy with Paraplatin® (carboplatin), Taxol ... - Cancer Consultants

Concurrent Radiation Therapy and Chemotherapy for Small Cell Lung ...  Mar 16, 2006
According to an article recently published in the British Journal of Cancer, chemotherapy including Paraplatin® (carboplatin), Taxol® (paclitaxel), and ... - Cancer Consultants

Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is ...  Mar 24, 2006
...erosion and three major chemotherapy drugs go off patent before 2012; Aventisi Taxotere (docetaxel), Bristol-Myers Squibbis Paraplatin (carboplatin) and Eli ... - Business Wire

Gemzar® May Improve Results of Taxol®/Paraplatin® Regimen for ...  09 Feb 2006
Researchers from Italy have reported that the addition Gemzar® (gemcitabine) to Taxol (paclitaxel)/Paraplatin (carboplatin) improves survival of patients with ... - Cancer Consultants

Bristol-Myers Squibb Company Reports Financial Results for the ...  Jan 25, 2006
Cefzil 75 89 (16)% 46 60 (23)% (15)% Baraclude 5 - - 4 - - N/A Oncology Taxol 181 256 (29)% 5 7 (29)% N/A Erbitux 121 88 38% 121 88 38% N/A Paraplatin 38 27 41 ... - PR Newswire

Addition of Gemzar® to Paclitaxel/Carboplatin Improves Survival ...  Jan 31, 2006
...of the chemotherapy agent Gemzar (gemcitabine) to the commonly used chemotherapy regimen paclitaxel (Taxol®) plus carboplatin (Paraplatin®) appears to ... - Cancer Consultants

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional